IGMSIGM Biosciences Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 8
Mkt Cap$78.71M
News
all
press releases
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
IGM Biosciences (IGMS) delivered earnings and revenue surprises of +626.67% and +4,388.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
More News
News Placeholder
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
Zacks
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
Zacks
News Placeholder
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates
chainwire
News Placeholder
Snowflake Stock Jumps Over 21% In Premarket Following Beat-and-Raise Q3: Retail Braces For ‘Parabolic’ Run
Snowflake CEO Sridhar Ramaswamy said, “Our obsessive drive to produce product cohesion and ease of use has built Snowflake into the easiest and most cost effective enterprise data platform.”
Stocktwits
<
...
1
>

Advertisement|Remove ads.